Pharmiweb.com RSS Feeds 
PharmiWeb Candidate Blog
Features
26 Nov 09
I recently surveyed a range of pharmaceutical HR managers and recruiters to find out what they consider to be the worst errors you can make on your CV when applying for a pharma job. The results were quite surprising and funny at times, so I have compiled the following 10 point checklist to help you with your CV.
Mike Wood
19 Nov 09
At the Financial Times Global Pharmaceutical and Biotech Conference this week, the keynote address was given by M. Chris Viehbacher, Chief Executive Officer of Sanofi-aventis.
Paul Hartigan
17 Nov 09
We're having a fascinating day at the Financial Times Global Pharmaceutical and Biotechnology conference on London.
Paul Hartigan
17 Nov 09
The craving for cheap drugs has never been greater. For those patients and policymakers in developing countries, the existence of parallel imports is less a concern than a blessing. Yet for pharmaceutical companies themselves, there is the concern that an increasing trade in parallel imports would severely damage research-intensive activities and ultimately slow down the development of the very same drugs that are being traded in ‘grey’ markets today.
Max Golby
02 Nov 09
Weekly Swine Flu Update for the Week Ending November 1st.
Max Golby
28 Oct 09
A difficult economic climate breeds desperation. This is perhaps one of the most plausible explanations for the apparent behaviour of several unethical recruiters in the marketplace.
Max Golby - PharmiWeb Field Reporter
27 Oct 09
Whatever happened to the days of donning your best suit and tie and going out and looking for a job? Knocking on doors and meeting prospective employers, dazzling them with your wit, intelligence and enthusiasm. Unfortunately that is not possible in today’s society.
Trevor Abbott - PharmiWeb Field Reporter
.jpg)
16 Oct 09
In this edition of StrategicEdge, CBR Pharma Insights discusses some of the recent rulings by the Indian courts and their impact on the pharmaceutical industry's increasing interest in India.
CBR Pharma Insights
13 Oct 09
Ever since the H1N1 virus first came onto the world map in April, ‘Where’s the vaccine?’ has been the cardinal question on everybody’s lips. As world governments scrambled to control the outbreak, supranational bodies such as the World Health Organization (WHO) threw themselves at the task of producing weekly updates for a virus which we originally knew very little about.
Max Golby
01 Oct 09
Weekly Swine Flu Update for the Week Ending October 2nd.
Max Golby
30 Sep 09
It is frightening because no one knows what's causing it, said a 28-year old law student who went to the St. Mark's Clinic in Greenwich Village last week complaining of swollen glands, thought to be one early symptom of the disease. Every week a new theory comes out about how you're going to spread it. - The New York Times , August 8th 1982.
Max Golby
28 Sep 09
A meta-analysis of the CRYSTAL and OPUS studies involving 845 patients with metastatic colorectal cancer (mCRC) tumours displaying the wild-type KRAS gene, has revealed first-line treatment with Erbitux (cetuximab) and FOLFOX4 or FOLFIRI chemotherapy significantly extends overall survival.
Olwen Glynn Owen
25 Sep 09
With the pharmaceutical industry heading into the well documented “expiry cliff” competition is rife. Quicker more cost effective methods of manufacturing must be found for big pharma to remain competitive and a clearer means of communication such as that seen at the NG Pharma Summit is clearly vital.
NG Online News
17 Sep 09
Hardly a day goes by without a new report, today AT Kearney, last week Roland Berger and before them IMS and PWC warning of a gloomy future for pharmaceutical companies and saying that they must change their ways.
Paul Dixey, Managing Partner, BlueLight Partners
16 Sep 09
Medical animation is increasinlgy being employed by pharmaceutical companies to explain the scientific rationale behind their products.
Faiz Kermani
16 Sep 09
In the eyes of many graduates, the economic recession has brought a new-found negativity to the job market. Thankfully, the climate is probably less dire than the situation sometimes imagined.
Max Golby
.jpg)
16 Sep 09
More than half of schizophrenia patients are expected to relapse within two years if untreated and 4 out of 5 within five years, according to experts. Antipsychotics can reduce the relapse rate so long as patients continue on treatment. However, adherence is notoriously poor. A new antippsychotic – asenapine – shows promise of being effective and better tolerated.
Olwen Glynn Owen
14 Sep 09
Weekly Swine Flu Update for the Week Ending September 10th
Max Golby
04 Sep 09
Weekly Swine Flu Update for the Week Ending September 4th.
Max Golby
03 Sep 09
Max Golby, Freelance Journalist, takes a look at the history of the e-Detailing market, considers what the e-Detail of the future might look like and asks what marketing departments can learn from an academic analysis of the instrument.
Max Golby
28 Aug 09
Weekly Swine Flu Update for the Week Ending August 27th.
Max Golby
21 Aug 09
Weekly Swine Flu Update for the Week Ending August 16th.
Max Golby
11 Aug 09
As Capitol Hill readies itself for the August Recess, and as President Barack Obama demands that a bill reach his desk in the Oval Office by October, healthcare reform still finds itself in more-or-less the same quagmire as it did in 1993. We take a look at the chances of comprehensive reform this year and tackle the nitty-gritty of one of the most complex and polarising issues of Washington politics today.
Max Golby
29 Jul 09
The field of Medical Communications offers a whole host of opportunities for new science graduates - both in medical publishing and pharma.
Max Golby
28 Jul 09
Ahead of the NHS Confederation Conference last month, David Nicholson, Chief Executive of NHS pulled no punches with his assessment of NHS finances.
Miriam George
27 Jul 09
ABPI have developed an on-line exam bookings website to facilitate the process of booking the ABPI Medical Representatives Exam.
ABPI
22 Jul 09
Generational stereotypes are never easy to swallow, but when it comes to doctors and an investment in social media, the new generations of medical professionals are increasingly going online for both professional collaboration and patient support.
Max Golby
15 Jul 09
With increased investment in R&D largely failing to fill drug development pipelines, the pharma industry is looking to get more bang for its R&D buck by generating some return out of failed drug candidates and extra return out of others. Drug re-positioning has become a key strategy for pharmaceutical groups, and according to Datamonitor, this approach is set to become more frequently employed.
Priyanka Adhikari
02 Jul 09
Getting a job in Clinical research or Regulatory Affairs can be tough at the best of times. Have you ever wondered how some people seem to know everybody and they are always the first to know what is happening in the industry and what roles are available?
Jonathan Hart-Smith
